Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 39 citing articles:

Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial
Jane Yardley, Mikko Kärppä, Yuichi Inoue, et al.
Sleep Medicine (2021) Vol. 80, pp. 333-342
Open Access | Times Cited: 59
The orexin story and orexin receptor antagonists for the treatment of insomnia
Clemens Muehlan, Catherine Roch, Cédric Vaillant, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 6
Open Access | Times Cited: 39
Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies
Russell Rosenberg, Leslie Citrome, Christopher L. Drake
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 2549-2566
Open Access | Times Cited: 47
Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease
J Kron, Ryan J. Keenan, Daniël Hoyer, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 359-386
Open Access | Times Cited: 15
Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 15
Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway
Bruce Corser, Erica Eves, Jennifer Warren-McCormick, et al.
Journal of Clinical Sleep Medicine (2023) Vol. 19, Iss. 6, pp. 1035-1042
Open Access | Times Cited: 13
Obstructive sleep apnea syndrome, orexin, and sleep–wake cycle: The link with the neurodegeneration
Mariana Fernandes, Claudio Liguori
Handbook of clinical neurology (2025), pp. 141-160
Closed Access
Response to “Letter to the editor regarding ‘Effect of lemborexant on sleep architecture in participants with insomnia disorder and mild obstructive sleep apnea’ by Kushida et al.”
Clete A. Kushida, Gary Zammit, Jocelyn Y. Cheng, et al.
Sleep Medicine (2025) Vol. 128, pp. 195-195
Closed Access
Effect of the new dual orexin receptor antagonist daridorexant on nighttime respiratory function and sleep in patients with mild and moderate obstructive sleep apnea
Marie‐Laure Boof, Jasper Dingemanse, Katharina Lederer, et al.
SLEEP (2020) Vol. 44, Iss. 6
Open Access | Times Cited: 33
Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem
Mike Ufer, Debra Kelsh, Kerri A. Schoedel, et al.
SLEEP (2021) Vol. 45, Iss. 3
Open Access | Times Cited: 31
The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System
Jennifer E. Fragale, Morgan H. James, Jorge A. Avila, et al.
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 117-127
Open Access | Times Cited: 29
Comorbid Insomnia and Sleep Apnea
Alexander Sweetman, Leon Lack, Megan R. Crawford, et al.
Sleep Medicine Clinics (2022) Vol. 17, Iss. 4, pp. 597-617
Open Access | Times Cited: 20
The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act
Margaret Moline, Shoji Asakura, Carsten Beuckman, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 699-711
Open Access | Times Cited: 11
Current Update on Clinically Relevant Sleep Issues in Parkinson’s Disease: A Narrative Review
Keisuke Suzuki
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 3, pp. 971-992
Open Access | Times Cited: 26
A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea
Jocelyn Y. Cheng, Daniel Lorch, Alan Lowe, et al.
Journal of Clinical Sleep Medicine (2023) Vol. 20, Iss. 1, pp. 57-65
Closed Access | Times Cited: 9
JCS 2023 Guideline on Diagnosis and Treatment of Sleep Disordered Breathing in Cardiovascular Disease
Takatoshi Kasai, Takashi Kohno, Wataru Shimizu, et al.
Circulation Journal (2024) Vol. 88, Iss. 11, pp. 1865-1935
Open Access | Times Cited: 3
An Update on Assessment, Therapeutic Management, and Patents on Insomnia
Amit Porwal, Yogesh Chand Yadav, Kamla Pathak, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-19
Open Access | Times Cited: 21
Effect of the novel dual orexin receptor antagonist daridorexant on night‐time respiratory function and sleep in patients with moderate chronic obstructive pulmonary disease
Marie‐Laure Boof, Jasper Dingemanse, Mareile Brunke, et al.
Journal of Sleep Research (2021) Vol. 30, Iss. 4
Closed Access | Times Cited: 19
Effect of lemborexant on sleep architecture in participants with insomnia disorder and mild obstructive sleep apnea
Clete A. Kushida, Gary Zammit, Jocelyn Y. Cheng, et al.
Sleep Medicine (2024)
Open Access | Times Cited: 2
Insomnia
Becky Lou, Margarita Oks
Clinics in Geriatric Medicine (2021) Vol. 37, Iss. 3, pp. 401-415
Closed Access | Times Cited: 17
Functional roles of orexin in obstructive sleep apnea: From clinical observation to mechanistic insights
Suchanya Sithirungson, Nuntigar Sonsuwan, Siriporn C. Chattipakorn, et al.
Sleep Medicine (2022) Vol. 101, pp. 40-49
Closed Access | Times Cited: 12
The Park Sleep subtype in Parkinson’s disease: from concept to clinic
Phoebe Tall, Mubasher A. Qamar, Ivana Rosenzweig, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 15, pp. 1725-1736
Open Access | Times Cited: 6
Proposal for Managing Cancer‐Related Insomnia: A Systematic Literature Review of Associated Factors and a Narrative Review of Treatment
Yoshinori Saeki, Yukiyoshi Sumi, Yukinori Ozaki, et al.
Cancer Medicine (2024) Vol. 13, Iss. 22
Open Access | Times Cited: 1
Review of the Efficacy and Safety of Lemborexant, a Dual Receptor Orexin Antagonist (DORA), in the Treatment of Adults With Insomnia Disorder
Kristin Waters
Annals of Pharmacotherapy (2021) Vol. 56, Iss. 2, pp. 213-221
Closed Access | Times Cited: 11
Cost-effectiveness analysis of lemborexant for treating insomnia in Japan: a model-based projection, incorporating the risk of falls, motor vehicle collisions, and workplace accidents
Shunya Ikeda, Mie Azuma, Kenichi Fujimoto, et al.
Psychological Medicine (2022) Vol. 52, Iss. 13, pp. 2822-2834
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top